University of California San Francisco Medical Center - Peds
Welcome,         Profile    Billing    Logout  
 25 Trials 
35 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lu, Ying
FUMANBA-03, NCT06464991: A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM

Recruiting
3
240
RoW
Equecabtagene Autoleucel Injection, FUCASO, Daratumumab, Pomalidomide, Bortezomib, Dexamethasone
Nanjing IASO Biotechnology Co., Ltd.
Multiple Myeloma
08/27
12/30
NCT06520163: Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

Recruiting
3
99
RoW
Etoposide, VP-16, Cytarabine, Ara-C, PEG-rhG-CSF, G-CSF, CHOP, Hyper-CVAD, ID-MTX + Ara-C, DA-EPOCH, GDP, GDPE, ICE, DICE
The Affiliated People's Hospital of Ningbo University, First Affiliated Hospital of Zhejiang University, First Affiliated Hospital of Wenzhou Medical University, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Jinhua People's Hospital, The Central Hospital of Lishui City, Shaoxing People's Hospital, Shaoxing Second Hospital, Zhejiang Provincial Tongde Hospital, Taizhou Hospital, Dongyang People's Hospital, Affiliated Hospital of Jiaxing University, Huizhou Municipal Central Hospital, Second Affiliated Hospital of Wenzhou Medical University, Ningbo Medical Center Lihuili Hospital, Jinhua Municipal Central Hospital
Non-Hodgkin's Lymphoma, Hematopoietic Stem Cell Mobilization
12/26
12/26
NCT06520176: Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients

Recruiting
3
99
RoW
Etoposide, VP-16, Cytarabine, Ara-C, Pegfilgrastim, PEG-rhG-CSF, Cyclophosphamide, Cy, G-CSF, Granulocyte Colony Stimulating Factor
The Affiliated People's Hospital of Ningbo University, First Affiliated Hospital of Zhejiang University, First Affiliated Hospital of Wenzhou Medical University, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, The Central Hospital of Lishui City, Jinhua People's Hospital, Shaoxing People's Hospital, Shaoxing Second Hospital, Zhejiang Provincial Tongde Hospital, Taizhou Hospital, Dongyang People's Hospital, Affiliated Hospital of Jiaxing University, Huizhou Municipal Central Hospital, Second Affiliated Hospital of Wenzhou Medical University, Ningbo Medical Center Lihuili Hospital, Jinhua Municipal Central Hospital
Multiple Myeloma, Hematopoietic Stem Cell Mobilization
12/26
12/26
TQ05105-III-01, NCT06682169: Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease

Recruiting
3
182
RoW
Rovadicitinib, Imatinib, Methotrexate, Mycophenolate mofetil, Rituximab
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Graft-versus-host Disease
10/29
12/30
NCT05780372: Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma

Recruiting
3
474
RoW
Intensity Modulated Radiation Therapy, IMRT, Chemotherapy
Sun Yat-sen University, Jiangxi Provincial Cancer Hospital, Zhejiang Cancer Hospital, Chongqing University Cancer Hospital, Dongguan People's Hospital, LiuZhou People's Hospital
Nasopharyngeal Carcinoma, Radiotherapy; Complications
05/25
05/28
NCT05084027: Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT

Recruiting
2
50
RoW
venetoclax combining with fludarabine and melphalan
First Affiliated Hospital of Zhejiang University, Sir Run Run Shaw Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial People's Hospital, The affiliated people's hospital of Ningbo University, First Affiliated Hospital of Wenzhou Medical University, Ningbo Hospital of Zhejiang University, The First Affiliated Hospital of Zhejiang Chinese Medical University
Hematologic Malignancy, Older Patients, Allogeneic Hematopoietic Stem Cell Transplantation
09/22
09/24
NCT06300320: A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease

Recruiting
2
40
RoW
TQ05105 tablets
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Graft Versus Host Disease
10/25
04/26
NCT06455410: GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma

Recruiting
2
216
RoW
GP, Adebrelimab, concurrent chemoradiotherapy (CCRT)
Sun Yat-sen University
Nasopharyngeal Carcinoma
06/26
06/28
NCT03118986: RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

Recruiting
2
200
Canada, US, RoW
Olanzapine, Placebo Oral Tablet
The Hospital for Sick Children, University of California, San Francisco, Children's Mercy Hospital Kansas City, St. Justine's Hospital, Columbia University, Medical University of South Carolina, CancerCare Manitoba, University of North Carolina, Chapel Hill, Nationwide Children's Hospital
Vomiting in Infants and/or Children, Nausea, Hematopoietic System--Cancer, Oncology
03/25
04/25
NCT05422066: Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma

Hourglass Jan 2023 - Dec 2023 : Market entry for endometrial cancer
Recruiting
2
50
RoW
Selinexor, ATG-010, Xpovio, Rituximab, RiTUXimab Injection, Cyclophosphamide, Cyclophosphamide Injection, Doxorubicin, Doxorubicin Hydrochloride, Vincristine, Vincristine Injection, Prednisone, Prednisone Oral Product
Li Zhiming, Antengene Corporation
DLBCL Germinal Center B-Cell Type
07/25
12/25
NCT05842512: Study of ADI-PEG 20 Versus Placebo in Subjects With NASH

Recruiting
2
40
RoW
ADI-PEG20, Pegargiminase, Placebo
Polaris Group
Nonalcoholic Steatohepatitis (NASH)
12/27
01/28
NCT02617407: Livionex Oral Microbiome and Dental Plaque Control in HSCT Recipients

Completed
1
44
US
Livionex® Dental Gel, Edathamil, PreviDent 5000 plus/Tom's of Maine Children's toothpaste, Over the counter toothpaste, Kolibree Toothbrush
University of California, San Francisco
Dental Plaque
01/20
01/20
NCT05528887: Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

Recruiting
1
10
RoW
Autologous CAR-T cells, Fludarabine, Fludara, Cyclophosphamide, Cytoxan
The Affiliated People's Hospital of Ningbo University, UTC Therapeutics Inc.
Relapsed/Refractory Hematological Malignancies, Lymphoma, Myeloma, Leukemia
06/24
06/26
NCT06142175: Relmacabtagene Autoleucel in Patients With LBCL

Recruiting
N/A
200
RoW
Relmacabtagene Autoleucel, JWCAR029
Shanghai Ming Ju Biotechnology Co., Ltd.
Large B-cell Lymphoma
12/24
12/24
NCT05510089: Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies

Recruiting
N/A
62
RoW
Etoposide, VP-16, Cytarabine, Ara-C, PEG-rhG-CSF
The Affiliated People's Hospital of Ningbo University
Hematological Malignancy
05/24
12/24
2022-YAN-030, NCT05536154: Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies

Recruiting
N/A
68
RoW
Etoposide, VP-16, Cytarabine, Ara-C, PEG-rhG-CSF
The Affiliated People's Hospital of Ningbo University
Lymphoma, Multiple Myeloma
06/24
10/24
NCT05589337: Baduanjin Training for Depression and Anxiety Patients

Recruiting
N/A
120
RoW
Baduanjin, Eight-section Brocade, Health education
Shanghai University of Traditional Chinese Medicine, Shanghai Mental Health Center
Depression Symptoms, Anxiety Symptoms
06/24
12/24
NCT05717790: Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma

Recruiting
N/A
288
RoW
Nimotuzumab, h-R3, BIOMAb EGFR, Gemcitabine, GEM, Cisplatin, DDP, Intensity-modulated radiotherapy, IMRT
Fourth Affiliated Hospital of Guangxi Medical University, People's Hospital of Baise, Second Affiliated Hospital of Guangzhou Medical University, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin Medical University, China, LiuZhou People's Hospital, The First People's Hospital of Qinzhou, Wuzhou Red Cross Hospital, Affiliated Hospital of Youjiang Medical University for Nationalities
Nasopharyngeal Carcinoma by AJCC V8 Stage
11/24
11/27
NCT04837222: A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma

Active, not recruiting
N/A
1000
RoW
No Intervention
Takeda
Lymphoma
06/26
06/26
NCT05355675: The Association of Microbiota Composition With cGVHD After Allo-HSCT

Recruiting
N/A
300
RoW
blood sample, stool sample
First Affiliated Hospital of Zhejiang University
Hematopoietic Stem Cell Transplantation, Hematologic Malignancy, Chronic Graft-versus-host-disease, Complication
05/25
05/25
NCT05940480: TCM Daoyin Therapy in Individuals At-risk for COPD

Recruiting
N/A
60
RoW
TCM Daoyin, Qigong, Health education
Shanghai University of Traditional Chinese Medicine, Changzheng Community Health Service Center of Putuo District, Shanghai
Chronic Obstructive Pulmonary Disease, Lung Diseases, Obstructive
06/27
12/27
Dvorak, Christopher
CSIDE, NCT03619551: Conditioning SCID Infants Diagnosed Early

Recruiting
2
64
Canada, US
Busulfan, Cell processing for TCRαβ+/CD19+ depletion, CliniMACS
Michael Pulsipher, MD
SCID
08/26
08/26
BRIDGE, NCT05787574: A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

Recruiting
2
39
US
Emapalumab, Fludarabine and Dexamethasone, Stem Cell Transplant
Memorial Sloan Kettering Cancer Center, Sobi, Inc.
Primary Immune Regulatory Disorder, Autoimmune Lymphoproliferative, Immune System Diseases
03/27
03/27
NCT02963064: JSP191 Antibody Targeting Conditioning in SCID Patients

Recruiting
1/2
40
US
Humanized anti-CD117 Monoclonal Antibody (JSP191)
Jasper Therapeutics, Inc.
SCID
06/25
06/28
NCT02617407: Livionex Oral Microbiome and Dental Plaque Control in HSCT Recipients

Completed
1
44
US
Livionex® Dental Gel, Edathamil, PreviDent 5000 plus/Tom's of Maine Children's toothpaste, Over the counter toothpaste, Kolibree Toothbrush
University of California, San Francisco
Dental Plaque
01/20
01/20
NCT01200017: Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant

No Longer Available
N/A
US
CD34+ enriched, T Cell Depleted donor stem cell product, bone marrow transplant
Christopher Dvorak
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Lymphomas, Bone Marrow Failure, Hemoglobinopathy, Immune Deficiency, Osteopetrosis, Cytopenias, Leukocyte Disorders, Anemia Due to Intrinsic Red Cell Abnormality
 
 
NCT03718546: Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors

Active, not recruiting
N/A
754
US
Center for International Blood and Marrow Transplant Research, University of Pittsburgh
Quality of Life
08/24
08/24
NCT01186913: Natural History Study of SCID Disorders

Enrolling by invitation
N/A
690
Canada, US
National Institute of Allergy and Infectious Diseases (NIAID), Primary Immune Deficiency Treatment Consortium (PIDTC), Office of Rare Diseases (ORD), National Center for Advancing Translational Sciences (NCATS)
Severe Combined Immunodeficiency (SCID), Leaky SCID, Omenn Syndrome, Reticular Dysgenesis, ADA SCID, XSCID
09/28
09/28
NCT04337515: A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant

Recruiting
N/A
90
US
CliniMacs®, CliniMACS® CD34 Reagent System
Christopher Dvorak
Graft Vs Host Disease, Graft-versus-host-disease
01/30
01/35
Magruder, Kevin
NCT06182410: Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma

Withdrawn
2
15
NA
Defibrotide, Noravid
University of California, San Francisco, Jazz Pharmaceuticals
Transplant-Associated Thrombotic Microangiopathy, Neuroblastoma, High-risk Neuroblastoma, Thrombotic Microangiopathies
05/27
05/27
ONC1701, NCT03509961: The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Recruiting
2
95
US
NGS-MRD, Myeloablative allogeneic HCT with a non-TBI conditioning regimen
Children's Hospital Los Angeles
B-cell Acute Lymphoblastic Leukemia
07/25
07/26
NCT04965597: Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)

Recruiting
2
40
US
Treosulfan, Dihydroxybusulfan, Ovastat, Treosulphan, Tresulfon, Trecondi, Fludarabine Phosphate, 2-fluoro-9-(5-O-phosphono-.beta.-D-arabinofuranosyl)-, 9H-purin-6-amine, 2-fluoro-9-(5-O-phosphono-beta-D-arabinofuranosyl), Beneflur, Fludara, Fludarabine-5'-Monophosphate, SH T 586, Tacrolimus, FK 506, Fujimycin, Hecoria, Prograf, Protopic, Methotrexate, Abitrexate, Alpha-Methopterin, Amethopterin, Brimexate, Emthexat, Emtexate, Farmitrexat, Methotrexate LPF, Methylaminopterin, Methotrexatum, Metotrexato, Novatrex, Rheumatrex, Texate, Tremetex, Trexeron, Trixilem, WR-19039, Lapine T-Lymphocyte Immune Globulin, Anti-Thymocyte Globulin Rabbit, Grafalon, Rabbit Anti-Human Thymocyte Globulin (RATG), Rabbit Anti-Thymocyte Globulin, Rabbit Antithymocyte Globulin, Rabbit ATG, rATG, Thymoglobulin, Antithymocyte globulin rabbit ATG, Imtix, Peripheral Blood Stem Cell Transplantation, PBPC transplantation, PBSCT, Peripheral Blood Progenitor Cell Transplantation, PERIPHERAL BLOOD STEM CELL TRANSPLANT, peripheral stem cell support, Peripheral Stem Cell Transplant, peripheral stem cell transplantation, Allogeneic Bone Marrow Transplantation, Allo BMT, Allogeneic Blood and Marrow Transplantation, Allogeneic BMT, Quality-of-Life Assessment, Quality of Life Assessment, Echocardiography, EC, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, Multi-Gated Acquisition Scan, MUGA Scan, Radionuclide Ventriculogram Scan, Radionuclide ventriculography, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Bone Marrow Biopsy, Bone Marrow Aspiration, Biospecimen Collection, Biological Sample Collection, X-Ray Imaging, Conventional X-Ray, Diagnostic Radiology, Computed Tomography, Computed Axial Tomography, CAT Scan, CT Scan
Fred Hutchinson Cancer Center, Blood and Marrow Transplant Clinical Trials Network, National Cancer Institute (NCI), National Marrow Donor Program, National Heart, Lung, and Blood Institute (NHLBI)
Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Diamond-Blackfan Anemia, Hereditary Sideroblastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Shwachman-Diamond Syndrome, Hematologic Neoplasm With Germline GATA2 Mutation, Hematologic Neoplasm With Germline SAMD9 Mutation, Hematologic Neoplasm With Germline SAMD9L Mutation
12/25
12/26
CSIDE, NCT03619551: Conditioning SCID Infants Diagnosed Early

Recruiting
2
64
Canada, US
Busulfan, Cell processing for TCRαβ+/CD19+ depletion, CliniMACS
Michael Pulsipher, MD
SCID
08/26
08/26
NCT04372524: Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study

Recruiting
N/A
350
Canada, US
University of British Columbia
Chronic Graft-versus-Host-Disease, Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation, Blood Cancer, Non-Malignant Hematologic and Lymphocytic Disorder
01/24
01/25
NCT03865589: Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome

Recruiting
N/A
250
US
Ultrasound Elastography
Children's Mercy Hospital Kansas City, Jazz Pharmaceuticals, Nationwide Children's Hospital, Dana-Farber Cancer Institute, University of California, San Francisco, University Hospitals Cleveland Medical Center, Duke University
Bone Marrow Transplant Complications, Sinusoidal Obstruction Syndrome, Veno Occlusive Disease, Hepatic, Stem Cell Transplant Complications
12/25
06/27

Download Options